r.weiss

TL2 · Galway

Contributes reviews on supplier material. Based in Galway.

Joined 8 August 2025 · last posted 2d

88 posts, newest first. Showing up to 150.

Retatrutide mass and identity: what a report should show Replied, post #27 · Compounds › Retatrutide · 26 Jul 2026 · 7 likes Confirming post #26 from a second method, which matters more than confirming it from a second person. If someone has run retatrutide mass and identity properly I would…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #97 · Practice › Administration · 17 Jul 2026 · 5 likes Before the thread moves on from Rotating between abdomen — what is the sample size behind the claim? I am not being difficult; I have seen the same figure quoted from…
Pooling trials with different estimands Replied, post #102 · Evidence › Meta-analyses · 16 Jul 2026 · 0 likes Double extraction with disagreement resolution is standard and is worth checking for, because single extraction errors are common and non-random.
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #37 · Pharmacology › Receptor biology · 6 Jul 2026 · 8 likes Taking post #34 at face value and following it one step further. Checked the receptor desensitisation claim against the primary source this morning. It survives, with a…
Why fasting instructions for oral semaglutide are not optional advice Replied, post #75 · Compounds › Oral incretins · 5 Jul 2026 · 18 likes PIONEER 6 is the cardiovascular outcome trial for oral semaglutide and it enrolled a diabetes population at high cardiovascular risk. Quoting it outside that population…
Personal or family history of medullary thyroid carcinoma Replied, post #18 · Safety › Contraindications · 26 Jun 2026 · 1 like Helpful, and easy to find again, which is half of what a good reply is.
Carryover and the ghost peak from last week's standard — what changed since Replied, post #55 · Analytics › HPLC & UHPLC · 21 Jun 2026 · 4 likes Trifluoroacetic acid at 0.1 per cent is the near-universal ion-pairing additive for this work, and it also raises the baseline at 214 nanometres. That is why the same…
What I would want from a home test that does not exist yet — what changed since Replied, post #56 · Analytics › Home & field testing · 15 Jun 2026 · 30 likes The honest cost comparison is a home kit against a single independent submission. For most people the second answers the question and the first answers a different,…
Insurance and replacement policies, compared Replied, post #13 · Sourcing › Logistics · 10 Jun 2026 · 1 like I had written a reply contradicting post #12 and deleted it. Here is what survived. Split shipments reduce single-point risk and increase the number of transits. Which…
Does a peptide degrade silently, with no visual change? Replied, post #43 · Practice › Storage & stability · 7 Jun 2026 · 0 likes Post #40 put the caveat in the right place and I want to underline it. Genuine question rather than a rhetorical one: has anyone here actually observed peptide, as…
Rotating between abdomen, thigh and upper arm: absorption differences — one year on Replied, post #72 · Practice › Administration · 2 Jun 2026 · 7 likes Post #69 describes the usual case. This is about the unusual one. If you have to inject at a different time of day than usual, that is a much smaller perturbation than…
What steady state means for the decision to escalate Replied, post #7 · Practice › Dosing & titration · 30 May 2026 · 14 likes Post #6 is the version of this I will quote in future. One addition. Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a…
A supplier who responds to a discrepancy with silence — what changed since Replied, post #53 · Sourcing › Red flags · 27 May 2026 · 4 likes Confirming post #51 from a second method, which matters more than confirming it from a second person. What I want from this supplier thread is the list of things that…
What a good consultation looks like from the other side Replied, post #43 · Clinical › Prescriber conversations · 23 May 2026 · 0 likes Fair, and the limits you put on it are the part I will remember.
The best-written scientific paper you have read Replied, post #53 · Lounge › Off topic · 19 May 2026 · 0 likes Worth separating best-written scientific paper as a question about the compound from best-written scientific paper as a question about the documentation. They get…
What the published dose-response for semaglutide actually looks like above 2.4 mg Replied, post #3 · Compounds › Semaglutide · 10 May 2026 · 0 likes The C-cell question: semaglutide triggered medullary thyroid carcinoma in rodent toxicology studies. A signal in rodents does not automatically appear in humans, but it…
The 2.5 mg starting dose is not a therapeutic dose — why that matters Replied, post #114 · Compounds › Tirzepatide · 7 May 2026 · 17 likes Research-use-only tirzepatide is not approved for human use and is not made to pharmaceutical standards. Anyone discussing it here is describing what they did, not…
Tracking semaglutide's approved indications across jurisdictions, dated Replied, post #4 · Compounds › Semaglutide · 4 May 2026 · 0 likes Adding the measurement that the opening post says would settle it. On dose steps: the four-week interval in the pivotal programme was a trial design choice, and slower…
Blind submission and why it changes minds — the long version Replied, post #50 · Sourcing › Independent verification · 1 May 2026 · 2 likes The record shows what was measured. Everything beyond that is inference and this site tries to keep the line visible. Take the reasoning and check the arithmetic; I do…
Reconstituting a multi-strength kit without mixing yourself up — what changed since Replied, post #8 · Practice › Reconstitution · 25 Apr 2026 · 0 likes What I can speak to on Reconstituting a multi-strength kit is narrow, so I will keep it narrow rather than generalising from it. Beyond that boundary I do not know.
Constipation management, with a dietitian's contribution Replied, post #57 · Practice › Side effects · 25 Apr 2026 · 17 likes I would put moderate confidence on the mainstream reading of constipation management and no more. That is not scepticism for its own sake; it is where the sourcing…
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #15 · Practice › Reconstitution · 18 Apr 2026 · 3 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Not the…
Chain of custody for a sample you posted yourself — one year on Replied, post #13 · Sourcing › Independent verification · 14 Apr 2026 · 6 likes Counterpoint on Chain of custody, offered without confidence: the same observation is consistent with a much duller explanation, and nobody has ruled the dull one out.
Follow-up: State-level differences that actually matter Replied, post #65 · Regional › North America · 7 Apr 2026 · 18 likes Whatever the answer on State-level differences turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, invite the…
Coming back to: Training through a dose escalation week Replied, post #59 · Nutrition & Training › Resistance training · 23 Mar 2026 · 25 likes Nothing here is medical advice and anybody with a relevant condition should have a programme reviewed by somebody qualified rather than assembled from a forum. Caveat:…
An ABAB design with a data table and honest limitations — a second dataset Replied, post #48 · Research Methods › N-of-1 designs · 9 Mar 2026 · 3 likes The practical version of ABAB design is three sentences long. The rigorous version is three pages and reaches the same conclusion with the conditions attached.
The lowest dose that does anything: is that a real question? Replied, post #7 · Practice › Dosing & titration · 1 Mar 2026 · 0 likes Taking post #6 at face value and following it one step further. Lowest dose would be much easier to settle if anyone reported the denominator. Almost nobody reports the…
Second pass at: Where impurities in solid-phase peptide synthesis come from Replied, post #47 · Analytics › Impurities & related substances · 26 Feb 2026 · 0 likes Thank you for taking the time. That was more work than a reply usually is.
Why one laboratory's 98.4% and another's 96.1% may not contradict — one year on Replied, post #13 · Analytics › Method validation · 23 Feb 2026 · 2 likes A stability-indicating method is one demonstrated to resolve the analyte from its degradation products, usually through forced degradation. Calling a method…
Request declined, with reasoning — what changed since Replied, post #15 · Meta › Feature requests · 23 Feb 2026 · 15 likes Effort estimation: some features are trivial to implement; others are substantial work. Staff will estimate effort when assessing whether a feature is feasible. That is…
Why "dose equivalence" between different incretin analogues is a weak concept Replied, post #41 · Practice › Dosing & titration · 17 Feb 2026 · 0 likes Concentration and dose get conflated constantly in this subcategory. Changing how much diluent you add changes the volume you draw and changes nothing about the dose.
Five questions in one post gets you one answer — how to split them Replied, post #12 · Start Here › How to Ask · 13 Feb 2026 · 0 likes Nobody minds being asked to explain a term. The people who use them most are the quickest to define them, and a question that stops to ask is usually a question that…
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #41 · Pharmacology › Pharmacokinetics · 13 Feb 2026 · 23 likes The arithmetic in post #40 is right; the assumption feeding it is the part to check. Practical answer on Washout, since the theoretical one is upthread: do the simplest…
Trifluoroacetate content and its consequences Replied, post #126 · Analytics › Impurities & related substances · 10 Feb 2026 · 16 likes That last point is the ceiling on what any purity figure can claim. A method that cannot see a species cannot exclude it, and no certificate says which species its…
Preprint servers and what screening they do Replied, post #47 · Evidence › Preprints · 6 Feb 2026 · 6 likes Post #45 put the caveat in the right place and I want to underline it. What changes between preprint and publication: authors respond to reviewer comments, re-analyse…
[2026 update] What a purity-only report leaves out Replied, post #8 · Sourcing › Independent verification · 25 Jan 2026 · 2 likes Post #7 is right about the mechanism and I think understates the practical bit. Since purity-only keeps coming up, it should probably be a maintained page rather than a…
Interpreting a result that disagrees with the supplier's certificate Replied, post #78 · Sourcing › Independent verification · 12 Jan 2026 · 0 likes Everything in post #74 holds. The case it does not cover is the one I have. Where the interpreting a result reasoning breaks down for me is the step from the group…
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #47 · Pharmacology › Receptor biology · 7 Jan 2026 · 27 likes Post #44 answers the question as asked. The question underneath it is different. GLP-1 receptor signalling: the GLP-1 receptor is expressed on beta cells (insulin…
Heterogeneity as information rather than as a nuisance Replied, post #53 · Evidence › Meta-analyses · 7 Jan 2026 · 10 likes Where I part company with post #49, and it is a narrow parting. The documentation on heterogeneity is better than this thread and I say that as someone who has posted…
Tirzepatide in type 2 diabetes: the SURPASS programme, summarised honestly — the long… Replied, post #39 · Compounds › Tirzepatide · 5 Dec 2025 · 7 likes Whatever the answer on Tirzepatide in type 2 diabetes turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public,…
Promotion criteria, and the one that stops most nominations — the long version Replied, post #100 · Documentation › Doc review · 25 Nov 2025 · 0 likes Building on post #99 rather than restating it. Promotion criteria has a well-known answer and a correct answer, and the interesting work is establishing that they are…
Coming back to: Over-dilution: when your dose falls below one readable graduation Replied, post #82 · Practice › Reconstitution · 16 Nov 2025 · 3 likes Taking post #79 at face value and following it one step further. Answering the Over-dilution question as asked, then the question I think is meant. As asked: yes, with…
Personal import allowances, compared — a second dataset Replied, post #17 · Access › International · 3 Nov 2025 · 0 likes Taking post #16 at face value and following it one step further. What I can speak to on Personal import allowances is narrow, so I will keep it narrow rather than…
A parcel that arrived warm: a decision process, not a verdict Replied, post #89 · Practice › Storage & stability · 17 Oct 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. On balance I…
Coming back to: Where the integrator drew the baseline, and how much it moved the number Replied, post #24 · Analytics › HPLC & UHPLC · 7 Oct 2025 · 0 likes Everything in post #22 holds. The case it does not cover is the one I have. This is why a purity figure without the underlying chromatogram is weaker evidence than it…
Analytical identity of BPC-157: a 15-mer with a simple mass Replied, post #7 · Compounds › Repair & healing peptides · 16 Sep 2025 · 30 likes The absence of adequately powered published randomised human trials is the central fact about BPC-157. This site states that plainly rather than hedging. Mechanistic…
Why catalogue breadth is not evidence of anything — what changed since Replied, post #41 · Compounds › Other compounds · 10 Sep 2025 · 8 likes A compound with no established assay is a compound where a certificate can say almost anything. That is not an accusation about anyone; it is a statement about what a…
Tirzepatide and nausea: is the profile genuinely different or just differently reported? Replied, post #2 · Compounds › Tirzepatide · 4 Sep 2025 · 2 likes Everything in the opening post holds. The case it does not cover is the one I have. Tirzepatide and nausea has been discussed here with more heat than it deserves,…
How the vendor documentation pages are maintained, and by whom — what changed since Replied, post #46 · Sourcing › Vendor reports · 26 Aug 2025 · 7 likes No disagreement from me. Posting only so the question does not look ignored.
Coming back to: What published stability data actually covers, and what it does not Replied, post #122 · Practice › Storage & stability · 25 Aug 2025 · 0 likes Clarity is a weak test. A solution can lose a significant fraction of its active content to degradation or adsorption while remaining perfectly clear. Genuinely open to…
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #114 · Compounds › Repair & healing peptides · 25 Aug 2025 · 1 like Post #112 is right about the mechanism and I think understates the practical bit. The lyophilised cake is worth looking at before adding diluent. A collapsed or…
Pages past their review date, listed Replied, post #20 · Meta › Wiki maintenance · 20 Aug 2025 · 0 likes Cross-referencing: if two pages should reference each other but do not, suggesting the cross-reference helps the maintainer see the connection.
Follow-up: History of disordered eating and why it changes the conversation Replied, post #64 · Clinical › Special populations · 20 Aug 2025 · 27 likes The honest answer on History of disordered eating is that it depends, and the useful part is the list of what it depends on. Four items, in rough order of how much they…
Specification in the result column: why that is a meaningful error Replied, post #26 · Analytics › COA interpretation · 3 Aug 2025 · 19 likes A chromatogram supplied as a small image is legible for peak shape and not for baseline detail. That is enough to sanity-check an integration and not enough to…
Second pass at: A history of disordered eating: proceeding carefully Replied, post #102 · Wellbeing › Mental health · 2 Aug 2025 · 17 likes Picking up post #99: that is the part I would want checked first. What I can speak to on history of disordered eating is narrow, so I will keep it narrow rather than…
Follow-up: Why appetite effects are mostly central Replied, post #2 · Pharmacology › Receptor biology · 17 Jul 2025 · 21 likes An honest declaration on appetite effects: I have a prior here and it is strong enough that you should weight what I say downward. Stating it rather than hiding it.
Thyroid function tests during substantial weight change Replied, post #6 · Clinical › Bloodwork · 15 Jul 2025 · 4 likes Analytical imprecision: any measurement has an error margin. A small difference in consecutive tests is usually measurement noise, not a real change. Knowing the…
Counter-ion content and its effect on measured mass Replied, post #74 · Analytics › Mass spectrometry · 25 Jun 2025 · 24 likes Source for the counter-ion content figure, since it was asked for. It is in the discussion rather than the abstract, which is why the version circulating is stronger…
Coming back to: Checking someone else's arithmetic: a worked example thread Replied, post #8 · Practice › Reconstitution · 22 Jun 2025 · 28 likes Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and neither helps a peptide go into solution any faster than patience does. Second-hand,…
[2026 update] Clearance pathways and what renal impairment changes Replied, post #52 · Pharmacology › Pharmacokinetics · 18 Jun 2025 · 4 likes Picking up post #51: that is the part I would want checked first. Half-life determines how quickly concentration approaches steady state and does not determine what the…
Journal club: STEP 4 and what a withdrawal design can prove Replied, post #53 · Evidence › Journal club · 8 Jun 2025 · 0 likes Where I part company with post #51, and it is a narrow parting. Small methodological point on STEP 4: repeating a measurement is cheap and resolves most of what is…
Sequence verification for an obscure compound: how it is done Replied, post #50 · Compounds › Other compounds · 1 Jun 2025 · 0 likes Research use only, not approved for human use, and in this subcategory the compounds vary enormously in how much is known about them. It is worth establishing which end…
Second pass at: How to research a compound with no human data without deceiving yourself Replied, post #55 · Compounds › Other compounds · 18 May 2025 · 9 likes Where the research a compound discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same…
A claim built entirely on a subgroup analysis Replied, post #35 · Evidence › Study critique · 15 May 2025 · 18 likes One more thing on claim built that took me far too long to see: the two figures people quote are not measuring the same quantity. Once you notice that, the apparent…
Shakes versus food: a pragmatic assessment — the long version Replied, post #24 · Nutrition & Training › Protein & intake · 14 May 2025 · 0 likes The mechanism is not mysterious. Substantial energy restriction with inadequate protein and no resistance stimulus loses lean tissue as well as fat.
Lean mass preservation: what the evidence supports Replied, post #12 · Outcomes › Body composition · 11 May 2025 · 29 likes Lean mass in these measurements includes water, so a change in hydration appears as a change in lean mass. If it helps: the failure mode here is usually boring rather…
Domestic fridge temperature mapping: a cheap experiment — what changed since Replied, post #83 · Devices › Cold chain · 11 Apr 2025 · 0 likes Offering a way to settle Domestic fridge temperature mapping rather than another opinion about it. Two measurements, taken the same way, a fortnight apart. If the…
Documenting a supplier's response to a discrepancy — does this still hold? Replied, post #9 · Sourcing › Vendor reports · 20 Mar 2025 · 24 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
One lot is one lot: when a report becomes a pattern — the long version Replied, post #88 · Sourcing › Vendor reports · 17 Mar 2025 · 23 likes A difference inside method repeatability is not a disagreement. Saying so in your own report prevents somebody else reading it as one. It cost nothing to check and…
Charge states for a 4 kDa peptide, worked through Replied, post #112 · Analytics › Mass spectrometry · 15 Mar 2025 · 21 likes The honest summary of what a mass result buys you: it narrows the field of what the material could be, considerably. It never closes it, and no certificate should be…
When "no data" is the complete and final answer Replied, post #117 · Compounds › Other compounds · 13 Mar 2025 · 23 likes Thymosin alpha-1 has a regulatory history in several jurisdictions and a real clinical literature, which puts it in a different evidential category from most of its…
Validating a method you did not develop — does this still hold? Replied, post #40 · Analytics › Method validation · 24 Feb 2025 · 1 like On Validating a method, I would rather understate and be corrected upward than overstate and be quoted. That is a house style here and it is a good one.
Distinguishing a deletion sequence by mass alone Replied, post #110 · Analytics › Mass spectrometry · 20 Feb 2025 · 0 likes Resolution: "high resolution" commonly means That is the practical version. The rigorous version is longer and says the same thing.
Scheduled maintenance and what will be unavailable Replied, post #44 · Meta › Announcements · 15 Feb 2025 · 31 likes Scheduled maintenance is one of those subjects where the general answer and the answer for a specific case diverge, and the thread will go in circles until someone says…
Second pass at: Cross-border purchase within the EU: the actual rules Replied, post #18 · Access › International · 29 Jan 2025 · 0 likes Cross-border prescribing and cross-border dispensing are different questions with different answers in most jurisdictions. It is one reading of the data and not the…
Molecular mass of semaglutide and why the figure differs between sources — does this… Replied, post #66 · Compounds › Semaglutide · 23 Dec 2024 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
Revisiting: Semaglutide formulation: what is in the licensed product besides the peptide Replied, post #15 · Compounds › Semaglutide · 18 Dec 2024 · 27 likes On post #13 — agreed on the reasoning, with one qualification. Counter-ion form matters for the arithmetic and is almost never stated. A vial labelled 5 mg of peptide…
Why "any advice?" is the least effective ending for a post Replied, post #127 · Start Here › How to Ask · 10 Dec 2024 · 20 likes Say what you have already ruled out. "It is not the diluent because I tried a second vial from a different box" saves three replies suggesting the diluent.
Coming back to: Renal impairment: what the labelling says about dose Replied, post #19 · Clinical › Special populations · 3 Dec 2024 · 29 likes Taking post #16 at face value and following it one step further. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in…
Coming back to: When to suspect the method rather than the sample Replied, post #18 · Analytics › Method validation · 2 Dec 2024 · 23 likes A method transferred between laboratories needs a demonstration that it performs equivalently, not just a document describing it. Transfer is where a great many…
The topic list is dense — is that deliberate? Replied, post #54 · Meta › Site feedback · 18 Nov 2024 · 24 likes That would also be the fastest way for a new member to understand what R6 actually catches, which is narrower than people assume from the text.
EMA product information as a primary source — does this still hold? Replied, post #3 · Regional › European Union · 14 Nov 2024 · 28 likes Everything in the opening post holds. The case it does not cover is the one I have. The reason EMA product information is hard to answer is that the obvious measurement…
Coming back to: Preparing for an appointment: one page, three questions Replied, post #73 · Clinical › Prescriber conversations · 8 Oct 2024 · 16 likes Grateful for the specificity. Vague answers to this question are what sent me looking.
Type 2 diabetes and the largest part of the evidence base — does this still hold? Replied, post #26 · Clinical › Comorbidities · 8 Oct 2024 · 0 likes The confident answers on Type 2 diabetes and the well-sourced answers are not the same answers, which is the most useful thing I have learned reading this category.
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #68 · Sourcing › Independent verification · 18 Sep 2024 · 0 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
Follow-up: Dead volume across syringe and needle combinations Replied, post #15 · Devices › Syringes & needles · 30 Jul 2024 · 1 like Barrel size determines resolution and nothing else. A 0.3 mL barrel and a 1 mL barrel deliver the same volume equally well; the smaller one lets you see what you are…
How this community labels and discusses unrefereed work Replied, post #90 · Evidence › Preprints · 17 Jul 2024 · 13 likes I read post #86 twice before replying, because I had assumed the opposite. Offering a way to settle community labels rather than another opinion about it. Two…
Where the four-week escalation interval comes from, and what it is not Replied, post #5 · Practice › Dosing & titration · 23 May 2024 · 4 likes The version of four-week escalation interval that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.